Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 115,736 |
|
|||||
| News | - | ||||||
| Day High | 4.09 | Low High |
|||||
| Day Low | 3.99 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Prelude Therapeutics Inc | PRLD | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.17 | 4.39% | 4.04 | 16:00:33 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.99 | 3.99 | 4.09 | 4.02 | 3.87 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 693 | 115,736 | $ 4.00 | $ 463,478 | - | 1.66 - 6.89 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:20:00 | formt | 638 | $ 4.04 | USD |
Prelude Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 220.78M | 54.92M | - | 0 | -121.83M | -2.22 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Prelude Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PRLD Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.16 | 4.18 | 3.42 | 3.66 | 54,867 | -0.12 | -2.88% |
| 1 Month | 4.80 | 5.83 | 3.42 | 4.54 | 43,127 | -0.76 | -15.83% |
| 3 Months | 3.25 | 5.83 | 2.62 | 4.07 | 70,440 | 0.79 | 24.31% |
| 6 Months | 2.10 | 5.83 | 1.66 | 3.25 | 140,516 | 1.94 | 92.38% |
| 1 Year | 6.30 | 6.89 | 1.66 | 3.72 | 125,312 | -2.26 | -35.87% |
| 3 Years | 36.36 | 45.33 | 1.66 | 13.68 | 189,939 | -32.32 | -88.89% |
| 5 Years | 25.76 | 95.375 | 1.66 | 20.83 | 193,033 | -21.72 | -84.32% |
Prelude Therapeutics Description
| Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need. |
